Skye Bioscience, Inc. — Director's Dealing 2018

Jan 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2018-01-18-07:00

Reporting Person: LYKOS COSMAS N (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-18-07:00	Common Stock	A	900000	$0.00	Acquired	4599400	Direct

Footnotes

F1: Restricted stock (the "RS") issued pursuant to the terms and conditions of a restricted stock agreement between the Reporting Person and the Issuer. After the Reporting Person had voluntarily agreed to delay equity awards in the prior two year period to benefit the Company, the Compensation Committee granted this RS award to the Reporting Person. The RS vests in two substantially equal installments each of the first and second anniversaries of the grant date of January 18, 2018, subject to continued employment with the Issuer through the applicable vesting date.